Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    17-July-2000      
Issue 95 Next Update - 14:00 UTC 08:00 EST    18-July-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya

Proceed To Article Side One: Nonoxynol-9 May Increase The Risk Of Catching HIV
A controversy erupted this past week when a study announced that Nonoxynol-9, a widely used spermicide, may increase the risk of catching HIV rather than lowering it. The research results were released at the XIII International AIDS conference. More...

Proceed To Article Side Two: Drug Company Says UNAIDS Condemnation of Nonoxynol-9 Results From a Faulty Study
A drug company commented in response to a press release issued by UNAIDS that Nonoxynol-9 may raise the rate of HIV infection rather than lower it. In the study, it was reported that Advantage-S is a sustained and controlled release formulation containing 52.5 MG of N9 per dose initially designed to be used once daily. WHO/UNAIDS conducted and published a study demonstrating it was safe to use at that dose. This was misleading. More...

Proceed To Article May 2000 Safety-Related Drug Labeling Changes
The FDA has released the drug safety-related drug labeling changes for the month of May. Vidyya presents the complete listing of these changes for your review. More...
Proceed To Article How to Report Adverse Reactions And Other Problems
Individuals can play an important public health role by reporting to the US Food and Drug Administration any adverse reactions or other problems with products the agency regulates. More...

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.